TL;DR
A Food Safety News Sunday Edition report describes a sharp setback for cultivated-meat ventures: several companies, including Meatable, CellRev, Upstream Foods and Believer Meats, ceased operations in 2025. The report links the closures to difficulty raising capital, high manufacturing costs and investor expectations for returns sooner than the sector may be able to deliver. It does not establish that cultivated meat as a whole has failed or provide a current tally of active companies.
Several cultivated-meat companies ceased operations in 2025, according to a Food Safety News Sunday Edition report, marking a sharp reversal for a sector that had drawn billions of dollars in investment. The report attributes the setbacks to companies’ difficulty securing more funding, costly biomanufacturing and a mismatch between the time needed to reach commercial scale and venture investors’ return expectations.
Get coffee and tea gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The report identifies Netherlands-based cultivated pork company Meatable, British cell-manufacturing company CellRev and Netherlands-based cultivated fish-fat developer Upstream Foods among the businesses that shut down in 2025. CellRev said it could not meet commercial milestones in time to secure investment, while Upstream Foods was unable to raise the capital it needed, the report says. Meatable ceased operations after acquiring Uncommon Bio’s cultivated-meat platform, which was intended to broaden its work beyond pork and beef into lamb and chicken.
The most prominent closure described was Believer Meats, which had completed a manufacturing plant near Raleigh, North Carolina. The report says the 200,000-square-foot facility, built at a cost of $125 million, was equipped with bioreactors and centrifuges and was expected to produce cultivated chicken. Believer had U.S. government approval, but lost a major financial backer and could not obtain a last-minute loan, the report says. The company stopped operating before producing meat at the plant, leaving the facility unused.
The closures followed a period of heavy investment. The Good Food Institute reported that cultivated-meat and seafood companies attracted more than $2.5 billion from 2021 through 2023; Food Safety News says that figure may have been an underestimate because investment was moving quickly. Funding came from venture capital, sovereign wealth funds and established meat companies, including Tyson Foods and JBS. The report does not provide a complete accounting of how much funding remains available or how many companies are still operating.
Why Production Costs Matter
The closures highlight a financing problem with consequences beyond individual startups: cultivated meat needs costly facilities and specialized production inputs before a company can demonstrate that it can sell at commercial scale. The report says bioreactors require substantial energy and specialized nutrient solutions, while building manufacturing capacity demands large capital outlays. A company can therefore face significant costs before revenue from large-scale production is established.
That timeline can conflict with venture capital funds’ typical five-to-seven-year return horizon. Food Safety News reports that commercial viability for cultivated meat may be at least a decade away, or longer. If investors are unwilling to keep financing research and factory development for that long, firms may run out of money even after completing major infrastructure. The Believer plant illustrates the gap between building a facility and sustaining a business able to operate it.
The development matters to readers because cultivated meat has been presented as a possible way to produce meat without raising and slaughtering whole animals. But the sector’s ability to deliver that product at meaningful scale, and whether it can compete commercially, remains unresolved. The reported shutdowns are evidence of serious business and manufacturing obstacles; they do not, by themselves, settle the technology’s long-term prospects.
Products Worth Considering
Breville Barista Express Espresso Machine with Built-In Grinder, Brushed Stainless Steel
Instant Pot InstantChill Ice Cream Maker with Rolled Ice Cream Plate, 2-Pint
Le Creuset Enameled Cast Iron Round Bread Oven, 9.5-Inch, Cerise
As an affiliate, we earn on qualifying purchases.
From Investment Boom to Closures
The cultivated-meat approach described in the report begins with animal cells collected from a living animal. The cells are placed in a culture medium containing materials needed for growth and cultivated in a bioreactor, with the aim of producing meat resembling conventional products. The report characterizes slaughter as unnecessary to this process, but does not provide details about the specific procedures or inputs used by each company.
Investor interest rose sharply around 2021, with companies seeking to move from development toward commercial production. By 2023, roughly half of venture funding went to five companies named in the report: Upside Foods, Believer Meats, Wildtype, Aleph Farms and Mosa Meat. Investors included government-backed sovereign wealth funds and established meat businesses as well as conventional venture funds.
The report sets that investment period against multiple shutdowns in 2025. It also recalls a 1931 essay by Winston Churchill that imagined growing edible chicken parts separately rather than raising a whole bird. The contrast is not proof that cultivated meat cannot succeed; it underlines how a long-standing idea has faced substantial technical, financial and commercial hurdles in attempts to bring it to market.
“We shall escape the absurdity of growing a whole chicken in order to eat the breast or wing, by growing these parts separately under a suitable medium.”
— Winston Churchill, in his 1931 essay “Fifty Years Hence,” quoted by Food Safety News
The Sector’s Remaining Unknowns
The report does not give a current, sector-wide count of active cultivated-meat companies, their cash reserves or their production capacity. It also does not establish whether the named closures were representative of the entire industry or whether other firms have secured new funding since 2025. The $2.5 billion investment figure covers 2021 through 2023, not the amount currently available to companies.
It remains unclear when cultivated meat could reach sustained commercial production, what it would cost to manufacture at scale, and whether it could compete on price with conventional meat. The report also does not detail the status of approvals or product sales across all markets. Believer Meats’ reported U.S. government approval, for example, should not be taken as evidence that every cultivated-meat product or company has approval.
Funding and Scale-Up Tests
The report names no specific upcoming funding round, reopening plan or production milestone for the companies that shut down. The next meaningful developments for the sector would be evidence that active firms can secure sustained financing, operate production facilities and meet commercial milestones. Until companies disclose such progress, the timing and scale of any wider market rollout remain uncertain.
Readers should also distinguish between a facility being built or a product receiving approval and meat being produced and sold at commercial scale. The 2025 closures show that reaching one milestone does not guarantee the financing needed for the next. Any assessment of the sector’s direction will depend on company disclosures and further reporting on costs, production and market availability.
Key Questions
What happened to cultivated-meat companies in 2025?
Food Safety News reports that Meatable, CellRev, Upstream Foods and Believer Meats ceased operations in 2025. The report links the closures to funding difficulties and, in some cases, missed commercial milestones.
Why did Believer Meats shut down?
According to the report, Believer Meats lost a major financial backer and management could not secure a last-minute loan. The company stopped operating before its completed North Carolina plant produced cultivated meat.
How much investment did the sector attract?
The Good Food Institute reported more than $2.5 billion in investment for cultivated-meat and seafood companies from 2021 through 2023. Food Safety News says the total may have been an underestimate; it is not a measure of current available funding.
What makes cultivated meat expensive to produce?
The report points to the capital needed for manufacturing facilities, along with the energy demands of bioreactors and the cost of specialized nutrient solutions. It does not provide a per-unit production cost or a comparison with conventional meat.
Do the closures mean cultivated meat will not reach the market?
No conclusion about the entire sector follows from the reported shutdowns. They show that several companies faced significant financing and production challenges, while the timing and commercial viability of cultivated meat remain uncertain.
Source: rss
